Latest NewsAug 14, 2019

Orgenesis Reorganizes Its Israel and Korea Subsidiaries to Support Continued Growth

Recent News

Aug 12, 2019
Orgenesis Second Quarter 2019 Revenue Increases 95% to a Record $7.8 Million
Jun 17, 2019
Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy
May 9, 2019
Orgenesis First Quarter 2019 Revenue Increases 177% to a Record $7.3 Million
Apr 30, 2019
Orgenesis Announces Planned Study to Confirm Suitability of Liver Cells as a Source for Personalized Cell Replacement Therapy for Insulin-Dependent Diabetic Patients
View All Press Releases

Latest EventFeb 12, 2019 • 9:00am EDT

2019 BIO CEO & Investor Conference
View All Events